Attached files

file filename
EX-3.2 - FIFTH AMENDED AND RESTATED OPERATING AGREEMENT OF ADVANCED BIOENERGY, LLC - Advanced BioEnergy, LLCd320746dex32.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 16, 2012

 

 

ADVANCED BIOENERGY, LLC

(Exact name of Registrant as Specified in Charter)

 

 

 

Delaware   000-52421   20-2281511

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

8000 Norman Center Drive

Suite 610 Bloomington, MN

  55437
(Address of Principal Executive Offices)   (Zip Code)

763-226-2701

Registrant’s Telephone Number, Including Area Code

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 16, 2012, the Board of Directors of Advanced BioEnergy, LLC (the “Company”) reconstituted the Nominating Committee as the Governance and Nominating Committee, which is now comprised of the following individuals:

Joshua M. Nelson, Chairman

Scott A. Brittenham

John E. Lovegrove

Bruce L. Rastetter

Richard R. Peterson

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

As stated below in Item 5.07, effective March 16, 2012, the Company’s members approved amendments to the Company’s Fourth Amended and Restated Operating Agreement (as amended and restated, the “Fifth Amended and Restated Operating Agreement”). The Company’s Fifth Amended and Restated Operating Agreement is being filed as an exhibit to this Current Report on Form 8-K.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On March 16, 2012, the Company held its Regular Meeting of Members (the “Regular Meeting”). Of the Company’s 24,714,180 membership units outstanding and entitled to vote at the Regular Meeting, 19,480,829 membership units or 78.8% were present either in person or by proxy.

The following describes the matters considered by the Company’s members at the Regular Meeting, as well as the final results of the votes cast at the meeting.

 

1. To approve a proposal amending and restating the Company’s Fourth Amended and Restated Operating Agreement.

 

For

   Against      Abstain  

19,026,827

     275,649         178,353   

 

2. To set at eight the number of directors to be elected for a term of one year.

 

For

   Against      Abstain  

19,146,660

     217,295         116,874   


3. To elect eight directors to serve for a period of one year and until their successors are elected and qualified.

 

Nominee

   For      Withhold  

Scott A. Brittenham

     19,144,695         336,134   

Jonathan K. Henness

     19,339,265         141,564   

John E. Lovegrove

     19,336,392         144,437   

Joshua M. Nelson

     19,369,266         111,563   

Bryan A. Netsch

     19,378,810         102,019   

Bruce L. Rastetter

     19,366,766         114,063   

Troy L. Otte

     19,351,310         129,519   

Richard R. Peterson

     19,378,810         102,019   

 

4. To ratify the appointment of McGladrey & Pullen LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2012.

 

For

   Against      Abstain  

19,368,387

     22,724         89,718   

 

5. To cast a non-binding advisory vote on executive compensation.

 

For

   Against      Abstain  

18,918,708

     337,092         225,029   

As a result, each nominee listed in Proposal 3 was elected as a director of the Company and Proposals 1, 2, 4 and 5 were approved.

 

Item 9.01 Financial Statements and Exhibits

The following exhibit is filed with this Form 8-K.

 

Exhibit No.

  

Description

3.2    Fifth Amended and Restated Operating Agreement of Advanced BioEnergy, LLC, effective as of March 16, 2012

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ADVANCED BIOENERGY, LLC
By:   /s/ Richard R. Peterson
  Richard R. Peterson
  President, Chief Executive Officer and
  Chief Financial Officer

Date: March 22, 2012